Variant report
Variant | rs1025438 |
---|---|
Chromosome Location | chr11:8905461-8905462 |
allele | G/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:8903715..8906519-chr11:8925903..8928507,2 | K562 | blood: |
No data |
No data |
No data |
No data |
rs_ID | r2[population] |
---|---|
rs10769977 | 0.85[CHB][hapmap];0.86[JPT][hapmap] |
rs10840156 | 0.83[CHB][hapmap];0.86[JPT][hapmap] |
rs12288224 | 0.83[AFR][1000 genomes];0.82[EUR][1000 genomes] |
rs12296005 | 1.00[ASW][hapmap];0.85[JPT][hapmap];1.00[MKK][hapmap];0.83[AFR][1000 genomes] |
rs12794962 | 0.87[CHD][hapmap];0.86[JPT][hapmap] |
rs12798311 | 0.86[ASN][1000 genomes] |
rs1347016 | 0.80[ASN][1000 genomes] |
rs2016844 | 0.91[CHD][hapmap];0.85[JPT][hapmap] |
rs2056903 | 0.92[CHB][hapmap];0.97[CHD][hapmap];1.00[JPT][hapmap];0.84[ASN][1000 genomes] |
rs2116510 | 0.92[CHB][hapmap];0.94[CHD][hapmap];1.00[JPT][hapmap];0.80[ASN][1000 genomes] |
rs2116511 | 0.92[CHB][hapmap];1.00[JPT][hapmap];0.80[ASN][1000 genomes] |
rs2163625 | 0.85[CHB][hapmap];0.82[CHD][hapmap];0.86[JPT][hapmap] |
rs2246878 | 0.85[ASN][1000 genomes] |
rs2247038 | 0.85[ASN][1000 genomes] |
rs2316541 | 0.82[ASN][1000 genomes] |
rs2568034 | 0.86[JPT][hapmap] |
rs2568042 | 0.86[CHD][hapmap];0.86[JPT][hapmap] |
rs2568047 | 0.87[CHD][hapmap];0.86[JPT][hapmap] |
rs2568069 | 0.92[CHB][hapmap];0.94[CHD][hapmap];1.00[JPT][hapmap];0.80[ASN][1000 genomes] |
rs2568074 | 0.85[ASN][1000 genomes] |
rs2568075 | 0.85[ASN][1000 genomes] |
rs2568077 | 0.85[ASN][1000 genomes] |
rs2568079 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.83[ASN][1000 genomes] |
rs2568081 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.82[ASN][1000 genomes] |
rs2568086 | 0.80[ASN][1000 genomes] |
rs2568087 | 0.80[ASN][1000 genomes] |
rs2653556 | 0.86[CHD][hapmap];0.86[JPT][hapmap] |
rs2653565 | 0.86[CHD][hapmap];0.86[JPT][hapmap] |
rs2653590 | 0.80[ASN][1000 genomes] |
rs2653601 | 0.92[CHB][hapmap];0.97[CHD][hapmap];1.00[JPT][hapmap];0.85[ASN][1000 genomes] |
rs2653604 | 0.92[CHB][hapmap];0.97[CHD][hapmap];1.00[JPT][hapmap];0.80[ASN][1000 genomes] |
rs2653611 | 0.83[ASN][1000 genomes] |
rs2742486 | 0.80[ASN][1000 genomes] |
rs2742487 | 0.92[CHB][hapmap];1.00[JPT][hapmap];0.80[ASN][1000 genomes] |
rs2742488 | 0.92[CHB][hapmap];1.00[JPT][hapmap];0.80[ASN][1000 genomes] |
rs2742491 | 0.92[CHB][hapmap];1.00[JPT][hapmap];0.80[ASN][1000 genomes] |
rs2742493 | 0.92[CHB][hapmap];0.97[CHD][hapmap];1.00[JPT][hapmap];0.80[ASN][1000 genomes] |
rs2742495 | 0.92[CHB][hapmap];1.00[JPT][hapmap];0.81[ASN][1000 genomes] |
rs2742496 | 0.92[CHB][hapmap];0.97[CHD][hapmap];1.00[JPT][hapmap];0.82[ASN][1000 genomes] |
rs2742497 | 1.00[CHB][hapmap];0.97[CHD][hapmap];1.00[JPT][hapmap];0.83[ASN][1000 genomes] |
rs2742504 | 0.83[ASN][1000 genomes] |
rs2742505 | 0.83[ASN][1000 genomes] |
rs2742512 | 0.85[ASN][1000 genomes] |
rs2742513 | 0.85[ASN][1000 genomes] |
rs2742514 | 0.92[CHB][hapmap];0.97[CHD][hapmap];1.00[JPT][hapmap];0.85[ASN][1000 genomes] |
rs2742519 | 0.92[CHB][hapmap];0.97[CHD][hapmap];1.00[JPT][hapmap];0.84[ASN][1000 genomes] |
rs2742521 | 0.86[JPT][hapmap] |
rs3751058 | 0.87[GIH][hapmap] |
rs3794150 | 0.87[GIH][hapmap] |
rs3829273 | 0.87[GIH][hapmap] |
rs4370967 | 0.87[CHD][hapmap];0.86[JPT][hapmap] |
rs72851596 | 1.00[AMR][1000 genomes];0.95[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs72852783 | 0.82[EUR][1000 genomes] |
rs72852790 | 0.82[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs72853712 | 0.84[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs909464 | 0.84[ASN][1000 genomes] |
rs982273 | 0.86[JPT][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv2758256 | chr11:8784813-9009573 | Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Active TSS Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 34 gene(s) | inside rSNPs | diseases |
2 | esv2759803 | chr11:8784813-9009573 | Flanking Active TSS Weak transcription Enhancers Strong transcription Active TSS Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 34 gene(s) | inside rSNPs | diseases |
3 | nsv435923 | chr11:8839325-9000602 | Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
4 | nsv832062 | chr11:8849295-9009472 | Enhancers Weak transcription Genic enhancers Flanking Active TSS Strong transcription Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
5 | esv3413845 | chr11:8887279-9285127 | Enhancers Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Active TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:8892800-8906600 | Weak transcription | Spleen | Spleen |
2 | chr11:8901000-8908000 | Weak transcription | Psoas Muscle | Psoas |
3 | chr11:8904000-8908000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
4 | chr11:8904400-8906200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr11:8905000-8906200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |